Key result
T2DM and LADA linked to widespread differential expression of lncRNAs compared to controls.
Why the study?
Long noncoding RNAs are closely related to diabetes pathogenesis, but their differential expression in T2DM and LADA and diagnostic profiles remain unclear.
Observational (n=12)
Significant differences in lncRNA expression profiles were identified between T2DM, LADA, and healthy controls, potentially aiding in differential diagnosis.
May aid LADA versus T2DM differentiation; leaves open biomarker validation in prospective studies.
Background. Long noncoding RNAs (lncRNAs) were previously found to be closely related to the pathogenesis of diabetes. Objectives. To reveal the differentially expressed lncRNAs and messenger RNAs (mRNAs) involved in type 2 diabetes mellitus (T2DM) and latent autoimmune diabetes in adults (LADA) and predict the lncRNA target genes to derive their expression profiles for the diagnosis of T2DM and LADA and their differential diagnosis. Methods. Twelve venous blood samples were collected from T2DM patients, LADA patients, and nondiseased subjects to obtain total RNAs. After removing rRNA from total RNAs to establish the desired library for sequencing, quality control and quantification analyses were carried out. The fragments per kilobase of exon model per million reads mapped (FPKM) of lncRNAs were calculated to construct the gene expression profiles of lncRNAs and mRNAs. Fold changes (fold change: 2.0) and p values ( p value: 0.05, FPKM ≥ 0.1) were calculated, and then differentially expressed lncRNAs and mRNAs were screened. To obtain the significantly coexpressed lncRNA-mRNA pairs, the lncRNA target genes were deduced according to the association between adjacent sites. Results. Compared to nondiseased controls, 68,763 versus 28,523 lncRNAs and 133 versus 1035 mRNAs were significantly upregulated and significantly downregulated, respectively, in T2DM patients. For LADA patients, 68,748 versus 28,538 lncRNAs and 219 versus 805 mRNAs were significantly upregulated and significantly downregulated, respectively, relative to nondiseased controls. Compared to T2DM patients, 74,207 versus 23,079 lncRNAs and 349 versus 137 mRNAs were significantly upregulated and significantly downregulated, respectively, in LADA patients. Based on the correlation analysis, seven lncRNA-mRNA pairs (BTG2, A2M, HECTD4, MBTPS1, DBH, FLVCR1, and NCBP2) were significantly coexpressed, and two lncRNAs (ENST00000608916 and ENST00000436373) were newly discovered. Conclusion. Significant differences in lncRNA expression were discovered among the three groups. Furthermore, after predicting lncRNA expression profiles, GO/KEGG pathway analysis could deduce the target gene function.
No takes yet. Share an insight, caveat, or question.
Yan et al. (2020) conducted an observational in Type 2 diabetes mellitus and latent autoimmune diabetes in adults (n=12). Type 2 diabetes mellitus and latent autoimmune diabetes in adults vs. Nondiseased subjects was evaluated on Differentially expressed lncRNAs and mRNAs. T2DM and LADA are associated with significant differential expression of lncRNAs compared to controls, including 68,763 upregulated and 28,523 downregulated lncRNAs in T2DM patients.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: